co-argi-peg
Recombinant proteinexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2015 (NCT02561234)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- ArginaseSupplementation
Arginase supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- co-argi-peg
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02732184 | Phase 1 | Aug 1, 2016 | Aeglea Biotherapeutics |
| NCT02561234 | Phase 1 | Oct 1, 2015 | Aeglea Biotherapeutics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aeglea Biotherapeutics | For profit | 2 | 2 | 1 | 2015 |
1 organizations
Page 1 / 1